NDC 70594-112-01 - Carboprost Tromethamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70594-112
- Requested NDC
- 70594-112-01
- Package NDCs from labels
- 70594-112-01, 70594-112-02
- Manufacturer
- Xellia Pharmaceuticals USA LLC | Steriscience Pte. Limited | Stelis Biopharma Limited
- Effective date
- 2023-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carboprost Tromethamine Injection, USP | Xellia Pharmaceuticals USA LLC | Steriscience Pte. Limited | Stelis Biopharma Limited | 2023-11-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70594-112-01 | Carboprost Tromethamine | 1 mL in 1 VIAL | SOLUTION | 1 | 2 | |
| 70594-112-02 | Carboprost Tromethamine | 10 in 1 CARTON | SOLUTION | 10 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70594-112-01 | ML - Milliliter | 70594-112 | 8a616d81-cdb1-461d-909f-5a70ea3f6fad | 1 | 2024-02-14 |
| 70594-112-02 | ML - Milliliter | 70594-112 | d16e2a4c-f4d3-4011-9101-8afdfdd2e959 | 1 | 2024-02-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| carboprost tromethamine | CARBOPROST TROMETHAMINE | Somerset Therapeutics, LLC | d79f4342-2d37-4a47-958e-ab800d4f3918 | 2026-06-05 | Boxed warning, Adverse reactions | U4526F86FJ |
| Hemabate | CARBOPROST TROMETHAMINE | Pharmacia & Upjohn Company LLC | 3d282998-ff0c-480a-bd80-155606ef0a65 | 2026-03-30 | Boxed warning, Warnings, Adverse reactions | 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Omnivium Pharmaceuticals LLC | 84efd1c0-6323-4469-9535-237f96fcb383 | 2026-03-12 | Boxed warning, Warnings, Adverse reactions | 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | Hikma Pharmaceuticals USA Inc. | aa42587d-7213-4a46-9050-9bbfbb081de5 | 2026-03-04 | Warnings, Adverse reactions | ANDA216897 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Alembic Pharmaceuticals Limited | d74a448c-ba91-4490-8550-9e675c39b427 | 2025-12-15 | Warnings, Adverse reactions | 238014 U4526F86FJ |
| carboprost tromethamine | CARBOPROST TROMETHAMINE | SOLA Pharmaceuticals, LLC | 32cb34f5-e199-4cf8-a848-aaec7d42bd10 | 2025-12-08 | Boxed warning, Warnings, Adverse reactions | 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Alembic Pharmaceuticals Inc. | c1cde9c7-b005-484f-8497-343c5ecd4f0a | 2025-12-08 | Warnings, Adverse reactions | 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | Sagent Pharmaceuticals | ffc3a941-4d73-4273-a879-1565133a4d5d | 2025-12-02 | Boxed warning, Adverse reactions | 238014 U4526F86FJ |
| carboprost tromethamine | CARBOPROST TROMETHAMINE | Amneal Pharmaceuticals LLC | eac3fd1c-ca4b-4aa3-9dc2-e7dbeb4c122a | 2025-10-31 | Adverse reactions | 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Eugia US LLC | a4c3b724-8c36-4d18-86b1-5ecee40cfbf4 | 2025-10-23 | Warnings, Adverse reactions | 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | ONESOURCE SPECIALTY PHARMA LIMITED | 461f80d0-b66c-f093-e063-6294a90a8893 | 2025-08-29 | Boxed warning, Adverse reactions | ANDA216897 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | Dr. Reddy's Laboratories Inc. | ce9f0ea6-69f9-6b68-2811-3b51e34acea6 | 2025-03-19 | Adverse reactions | 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Caplin Steriles Limited | 42736d6a-0ab3-4c3c-897d-406aad5a49c2 | 2025-01-20 | Adverse reactions | 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | ANI Pharmaceuticals, Inc. | 4dcda284-cfea-4b95-b432-a3d5af536e63 | 2024-12-20 | Boxed warning, Warnings, Adverse reactions | 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Dr. Reddys Laboratories Inc. | 2fd306a6-bf50-a354-46e5-d9fa8da619af | 2024-12-20 | Adverse reactions | 238014 U4526F86FJ |
| CARBOPROST TROMETHAMINE | CARBOPROST TROMETHAMINE | Dr. Reddys Laboratories Inc. | 1fc164ae-9964-17b3-4b92-d25b0ddb805e | 2024-12-19 | Adverse reactions | 238014 U4526F86FJ |
| carboprost tromethamine | CARBOPROST TROMETHAMINE | Hospira, Inc. | e5054c6a-c54e-4ddf-8280-a154b90cac07 | 2024-04-15 | Adverse reactions | 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | Micro Labs Limited | a8a6acbf-81db-4fe3-aec8-ee7aa7af4d32 | 2024-04-05 | Adverse reactions | 238014 U4526F86FJ |
| Carboprost Tromethamine | CARBOPROST TROMETHAMINE | Xellia Pharmaceuticals USA LLC | 8a1284cf-002f-4887-a3c0-d73d04b2b869 | 2023-11-01 | Warnings, Adverse reactions | ANDA216897 70594-112-02 70594-112-01 70594-112 70594011201 238014 855a4bbb-d273-4372-8221-8fcff32bee92 8a1284cf-002f-4887-a3c0-d73d04b2b869 U4526F86FJ |
| carboprost tromethamine | CARBOPROST TROMETHAMINE | Gland Pharma Limited | 5902edd8-16b3-4f52-ac35-b0f4dfb5ab6a | 2023-08-08 | Adverse reactions | 238014 U4526F86FJ |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.